glp 1 drugs semaglutide Novo Nordisk Expands GLP-1 Access Through Telehealth Providers No Difference Seen in Risk

CJC-1295 is a Growth Hormone Releasing Hormone (GHRH) analog that stimulates the anterior pituitary to release more endogenous growth hormone

Interim analysis of the effects of exenatide treatment on A1C, weight and cardiovascular risk factors over 82 weeks in 314 overweight patients with type 2 diabetes L Blonde 1, E J Klein, J Han, B Zhang, S M Mac, T H Poon, K L Taylor, M E Trautmann, D D Kim, D M Kendall Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity List of authors

These medications commonly cause nausea, vomiting, and diarrhea, particularly during dose initiation and escalation

In any case, consult your doctor before stopping any GLP-1 medication, as abruptly stopping these medications can lead to adverse effects